AKT1 and breast cancer: For example, low miR-451/high YWHAZ expression was observed to promote cell proliferation and inhibit apoptosis through AKT targeting in AML and activate growth factor receptors and kinases (HER2, EGFR, AKT, and MAPK) involved in endocrine resistance in breast cancer 46, 54.